Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
387
archived clinical trials in
Iron Deficiency Anemia

Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With Moderate to Severe Chronic Kidney Disease (CKD) With Iron Deficiency
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
2072
mi
from 98109
Birmingham, AL
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With Moderate to Severe Chronic Kidney Disease (CKD) With Iron Deficiency
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
2072
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials
Iron Isomaltoside and Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)
A Phase III, Randomised, Open-label, Comparative Safety and Efficacy Trial of Intravenous Iron Isomaltoside (Monofer®) and Iron Sucrose in Subjects With Iron Deficiency Anemia (Ferwon IDA)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2730
mi
from 98109
Miami, FL
Iron Isomaltoside and Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)
A Phase III, Randomised, Open-label, Comparative Safety and Efficacy Trial of Intravenous Iron Isomaltoside (Monofer®) and Iron Sucrose in Subjects With Iron Deficiency Anemia (Ferwon IDA)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2730
mi
from 98109
Miami, FL
Click here to add this to my saved trials
BioFe, Medical Food for the Dietary Management of Iron Deficiency
A Clinical Trial of BioFe, Medical Food for the Dietary Management of Iron Deficiency
Status: Enrolling
Updated:  12/31/1969
Green and Seidner Family Practice Associates
2358
mi
from 98109
Lansdale, PA
BioFe, Medical Food for the Dietary Management of Iron Deficiency
A Clinical Trial of BioFe, Medical Food for the Dietary Management of Iron Deficiency
Status: Enrolling
Updated: 12/31/1969
Green and Seidner Family Practice Associates
2358
mi
from 98109
Lansdale, PA
Click here to add this to my saved trials
BioFe, Medical Food for the Dietary Management of Iron Deficiency
A Clinical Trial of BioFe, Medical Food for the Dietary Management of Iron Deficiency
Status: Enrolling
Updated:  12/31/1969
Frontier Clinical Research, LLC
2164
mi
from 98109
Scottdale, PA
BioFe, Medical Food for the Dietary Management of Iron Deficiency
A Clinical Trial of BioFe, Medical Food for the Dietary Management of Iron Deficiency
Status: Enrolling
Updated: 12/31/1969
Frontier Clinical Research, LLC
2164
mi
from 98109
Scottdale, PA
Click here to add this to my saved trials
BioFe, Medical Food for the Dietary Management of Iron Deficiency
A Clinical Trial of BioFe, Medical Food for the Dietary Management of Iron Deficiency
Status: Enrolling
Updated:  12/31/1969
Frontier Clinical Research, LLC
2162
mi
from 98109
Smithfield, PA
BioFe, Medical Food for the Dietary Management of Iron Deficiency
A Clinical Trial of BioFe, Medical Food for the Dietary Management of Iron Deficiency
Status: Enrolling
Updated: 12/31/1969
Frontier Clinical Research, LLC
2162
mi
from 98109
Smithfield, PA
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
California Institute of Renal Research
1072
mi
from 98109
Chula Vista, CA
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
California Institute of Renal Research
1072
mi
from 98109
Chula Vista, CA
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
California Institute of Renal Research Inc.
1084
mi
from 98109
El Centro, CA
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
California Institute of Renal Research Inc.
1084
mi
from 98109
El Centro, CA
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
California Institute of Renal Research
1050
mi
from 98109
Poway, CA
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
California Institute of Renal Research
1050
mi
from 98109
Poway, CA
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
Denver Nephrologists, PC
1025
mi
from 98109
Denver, CO
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
Denver Nephrologists, PC
1025
mi
from 98109
Denver, CO
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
Southeastern Clinical Research Institute, LLC
2300
mi
from 98109
Augusta, GA
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
Southeastern Clinical Research Institute, LLC
2300
mi
from 98109
Augusta, GA
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Consultants
1503
mi
from 98109
Kansas City, MO
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Consultants
1503
mi
from 98109
Kansas City, MO
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
Sierra Nevada Nephrology Consultants
574
mi
from 98109
Reno, NV
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
Sierra Nevada Nephrology Consultants
574
mi
from 98109
Reno, NV
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
Mountain Kidney and Hypertension Associates
2187
mi
from 98109
Asheville, NC
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
Mountain Kidney and Hypertension Associates
2187
mi
from 98109
Asheville, NC
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
Eastern Nephrology Associates
2426
mi
from 98109
Greenville, NC
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
Eastern Nephrology Associates
2426
mi
from 98109
Greenville, NC
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
Southeastern Nephrology Associates
2459
mi
from 98109
Jacksonville, NC
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
Southeastern Nephrology Associates
2459
mi
from 98109
Jacksonville, NC
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
Eastern Nephrology Associates, PLLC
2462
mi
from 98109
New Bern, NC
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
Eastern Nephrology Associates, PLLC
2462
mi
from 98109
New Bern, NC
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
Clinical Advancement Center, PLLC
1786
mi
from 98109
San Antonio, TX
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
Clinical Advancement Center, PLLC
1786
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
Arizona Kidney Disease and Hypertension Center
1112
mi
from 98109
Phoenix, AZ
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
Arizona Kidney Disease and Hypertension Center
1112
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
Miami Kidney Group
2731
mi
from 98109
Miami, FL
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
Miami Kidney Group
2731
mi
from 98109
Miami, FL
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
Kidney and Hypertension Specialists of Miami
mi
from 98109
Miami, FL
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
Kidney and Hypertension Specialists of Miami
mi
from 98109
Miami, FL
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
Renal Associates, LLC
2207
mi
from 98109
Columbus, GA
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
Renal Associates, LLC
2207
mi
from 98109
Columbus, GA
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
Research by Design, LLC
1735
mi
from 98109
Chicago, IL
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
Research by Design, LLC
1735
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
South Mississippi Medical Research, LLC
2121
mi
from 98109
Gulfport, MS
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
South Mississippi Medical Research, LLC
2121
mi
from 98109
Gulfport, MS
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
Division of Kidney and Hypertension Research
mi
from 98109
Great Neck, NY
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
Division of Kidney and Hypertension Research
mi
from 98109
Great Neck, NY
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
Columbia Nephrology Associates
2319
mi
from 98109
Columbia, SC
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
Columbia Nephrology Associates
2319
mi
from 98109
Columbia, SC
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
Nephrology Associates, PC
1971
mi
from 98109
Nashville, TN
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
Nephrology Associates, PC
1971
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
San Antonio Kidney Disease Center Physicians Group
1787
mi
from 98109
San Antonio, TX
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
San Antonio Kidney Disease Center Physicians Group
1787
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
Hypertension Nephrology Association
2414
mi
from 98109
Eatontown, NJ
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
Hypertension Nephrology Association
2414
mi
from 98109
Eatontown, NJ
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
Metrolina Nephrology Associates, PA
2282
mi
from 98109
Charlotte, NC
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
Metrolina Nephrology Associates, PA
2282
mi
from 98109
Charlotte, NC
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
Southeastern Nephrology
2455
mi
from 98109
Wilmington, NC
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
Southeastern Nephrology
2455
mi
from 98109
Wilmington, NC
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
South Carolina Nephrology & Hypertension Center
2351
mi
from 98109
Orangeburg, SC
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
South Carolina Nephrology & Hypertension Center
2351
mi
from 98109
Orangeburg, SC
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
Research Management, Inc., #2
mi
from 98109
Austin, TX
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
Research Management, Inc., #2
mi
from 98109
Austin, TX
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
Research Management, Inc., #1
mi
from 98109
Austin, TX
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
Research Management, Inc., #1
mi
from 98109
Austin, TX
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated:  12/31/1969
P&I Clinical Research
1836
mi
from 98109
Lufkin, TX
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Status: Enrolling
Updated: 12/31/1969
P&I Clinical Research
1836
mi
from 98109
Lufkin, TX
Click here to add this to my saved trials
Iron Deficiency and FGF23 Regulation in CKD and HF
Iron Deficiency and Fibroblast Growth Factor 23 Regulation in Chronic Kidney Disease and Heart Failure
Status: Enrolling
Updated:  12/31/1969
Northwestern University
1733
mi
from 98109
Chicago, IL
Iron Deficiency and FGF23 Regulation in CKD and HF
Iron Deficiency and Fibroblast Growth Factor 23 Regulation in Chronic Kidney Disease and Heart Failure
Status: Enrolling
Updated: 12/31/1969
Northwestern University
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Helicobacter Pylori Eradication Trial to Reduce Iron Deficiency in Children
Randomized Field Intervention Trial of H. Pylori Eradication to Reduce Iron Deficiency Among Children in El Paso, Texas
Status: Enrolling
Updated:  6/26/2009
Texas Tech University School of Medicine
1378
mi
from 98109
El Paso, TX
Helicobacter Pylori Eradication Trial to Reduce Iron Deficiency in Children
Randomized Field Intervention Trial of H. Pylori Eradication to Reduce Iron Deficiency Among Children in El Paso, Texas
Status: Enrolling
Updated: 6/26/2009
Texas Tech University School of Medicine
1378
mi
from 98109
El Paso, TX
Click here to add this to my saved trials
IV Iron Sucrose vs Oral FeSO4 in Treating IDA in Pediatric IBD
Intravenous Iron Sucrose Versus Oral Ferrous Sulfate in Treating Iron Deficiency Anemia in Pediatric Inflammatory Bowel Disease
Status: Enrolling
Updated:  9/21/2011
Children's Hospital of Michigan
1932
mi
from 98109
Detroit, MI
IV Iron Sucrose vs Oral FeSO4 in Treating IDA in Pediatric IBD
Intravenous Iron Sucrose Versus Oral Ferrous Sulfate in Treating Iron Deficiency Anemia in Pediatric Inflammatory Bowel Disease
Status: Enrolling
Updated: 9/21/2011
Children's Hospital of Michigan
1932
mi
from 98109
Detroit, MI
Click here to add this to my saved trials
Prevention of Iron Deficiency in Breastfed Infants
Prevention of Iron Deficiency in Breastfed Infants
Status: Enrolling
Updated:  4/26/2012
University of Iowa
1556
mi
from 98109
Iowa City, IA
Prevention of Iron Deficiency in Breastfed Infants
Prevention of Iron Deficiency in Breastfed Infants
Status: Enrolling
Updated: 4/26/2012
University of Iowa
1556
mi
from 98109
Iowa City, IA
Click here to add this to my saved trials
Enhancing Treatment of Iron Deficiency and Iron Deficiency Anemia With an Antioxidant, Vitamin E
Enhancing Treatment of Iron Deficiency and Iron Deficiency Anemia With an Antioxidant, Vitamin E
Status: Enrolling
Updated:  7/11/2013
University of Colorado Denver
1026
mi
from 98109
Aurora, CO
Enhancing Treatment of Iron Deficiency and Iron Deficiency Anemia With an Antioxidant, Vitamin E
Enhancing Treatment of Iron Deficiency and Iron Deficiency Anemia With an Antioxidant, Vitamin E
Status: Enrolling
Updated: 7/11/2013
University of Colorado Denver
1026
mi
from 98109
Aurora, CO
Click here to add this to my saved trials
Impact of Host Iron Status and Iron Supplement Use on Erythrocytic Stage of Plasmodium Falciparum
Impact of Host Iron Status and Iron Supplement Use on Growth and Viability of the Erythrocytic Stage of Plasmodium Falciparum
Status: Enrolling
Updated:  1/6/2014
University of North Carolina at Chapel Hill
2329
mi
from 98109
Chapel Hill, NC
Impact of Host Iron Status and Iron Supplement Use on Erythrocytic Stage of Plasmodium Falciparum
Impact of Host Iron Status and Iron Supplement Use on Growth and Viability of the Erythrocytic Stage of Plasmodium Falciparum
Status: Enrolling
Updated: 1/6/2014
University of North Carolina at Chapel Hill
2329
mi
from 98109
Chapel Hill, NC
Click here to add this to my saved trials
A Randomized, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Against Placebo
A Phase III, Randomised, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Against Placebo in Subjects With Iron Deficiency Anaemia and Who Are Intol-erant or Unresponsive to Oral Iron Therapy
Status: Enrolling
Updated:  12/17/2014
Clinical Research Facility
2328
mi
from 98109
Baltimore, MD
A Randomized, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Against Placebo
A Phase III, Randomised, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Against Placebo in Subjects With Iron Deficiency Anaemia and Who Are Intol-erant or Unresponsive to Oral Iron Therapy
Status: Enrolling
Updated: 12/17/2014
Clinical Research Facility
2328
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Short-Term Effects & Safety of an Accelerated Intravenous Iron Regimen in Patients With Heart Failure
Short-Term Effects & Safety of an Accelerated Intravenous Iron Regimen in Patients With Heart Failure
Status: Enrolling
Updated:  8/12/2015
University of North Carolina Hospitals and Clinics
2345
mi
from 98109
Chapel Hill, NC
Short-Term Effects & Safety of an Accelerated Intravenous Iron Regimen in Patients With Heart Failure
Short-Term Effects & Safety of an Accelerated Intravenous Iron Regimen in Patients With Heart Failure
Status: Enrolling
Updated: 8/12/2015
University of North Carolina Hospitals and Clinics
2345
mi
from 98109
Chapel Hill, NC
Click here to add this to my saved trials
Iron Replacement in Blood Donors
Iron Replacement in Blood Donors
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Iron Replacement in Blood Donors
Iron Replacement in Blood Donors
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Click here to add this to my saved trials
Strategies to Reduce Iron Deficiency
Caring for Those Who Share: Mitigating Iron Deficiency In Regular Blood Donors
Status: Enrolling
Updated:  12/21/2015
American Red Cross, Connecticut Region
2424
mi
from 98109
Farmington, CT
Strategies to Reduce Iron Deficiency
Caring for Those Who Share: Mitigating Iron Deficiency In Regular Blood Donors
Status: Enrolling
Updated: 12/21/2015
American Red Cross, Connecticut Region
2424
mi
from 98109
Farmington, CT
Click here to add this to my saved trials
Strategies to Reduce Iron Deficiency
Caring for Those Who Share: Mitigating Iron Deficiency In Regular Blood Donors
Status: Enrolling
Updated:  12/21/2015
Westat, Inc.
2309
mi
from 98109
Rockville, MD
Strategies to Reduce Iron Deficiency
Caring for Those Who Share: Mitigating Iron Deficiency In Regular Blood Donors
Status: Enrolling
Updated: 12/21/2015
Westat, Inc.
2309
mi
from 98109
Rockville, MD
Click here to add this to my saved trials
Strategies to Reduce Iron Deficiency
Caring for Those Who Share: Mitigating Iron Deficiency In Regular Blood Donors
Status: Enrolling
Updated:  12/21/2015
The Institute for Transfusion Medicince
2132
mi
from 98109
Pittsburgh, PA
Strategies to Reduce Iron Deficiency
Caring for Those Who Share: Mitigating Iron Deficiency In Regular Blood Donors
Status: Enrolling
Updated: 12/21/2015
The Institute for Transfusion Medicince
2132
mi
from 98109
Pittsburgh, PA
Click here to add this to my saved trials
Strategies to Reduce Iron Deficiency
Caring for Those Who Share: Mitigating Iron Deficiency In Regular Blood Donors
Status: Enrolling
Updated:  12/21/2015
BloodCenter of Wisconsin
1686
mi
from 98109
Milwaukee, WI
Strategies to Reduce Iron Deficiency
Caring for Those Who Share: Mitigating Iron Deficiency In Regular Blood Donors
Status: Enrolling
Updated: 12/21/2015
BloodCenter of Wisconsin
1686
mi
from 98109
Milwaukee, WI
Click here to add this to my saved trials
Probiotics in the Treatment of Iron Deficiency in Children With Restless Leg Syndrome
Probiotics in the Treatment of Iron Deficiency in Children With Restless Leg Syndrome-A Double-blind, Randomized Controlled Study
Status: Enrolling
Updated:  1/19/2016
Childrens Hospitals And Clinics Of Minnesota
1399
mi
from 98109
St. Paul, MN
Probiotics in the Treatment of Iron Deficiency in Children With Restless Leg Syndrome
Probiotics in the Treatment of Iron Deficiency in Children With Restless Leg Syndrome-A Double-blind, Randomized Controlled Study
Status: Enrolling
Updated: 1/19/2016
Childrens Hospitals And Clinics Of Minnesota
1399
mi
from 98109
St. Paul, MN
Click here to add this to my saved trials
Universal Screening for Tuberculosis and Anemia With the CHICA System
Universal Screening for Tuberculosis and Anemia With the CHICA System
Status: Enrolling
Updated:  1/22/2016
Children's Health Services Research
1868
mi
from 98109
Indianapolis, IN
Universal Screening for Tuberculosis and Anemia With the CHICA System
Universal Screening for Tuberculosis and Anemia With the CHICA System
Status: Enrolling
Updated: 1/22/2016
Children's Health Services Research
1868
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
Adherence With Iron Sprinkles Among High-Risk Infants
Adherence With Iron Sprinkles Among High-Risk Infants
Status: Enrolling
Updated:  2/2/2016
Whittier Street Health Center
2485
mi
from 98109
Boston, MA
Adherence With Iron Sprinkles Among High-Risk Infants
Adherence With Iron Sprinkles Among High-Risk Infants
Status: Enrolling
Updated: 2/2/2016
Whittier Street Health Center
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials